Schaper Benz & Wise Investment Counsel Inc Abbott Laboratories Transaction History

Schaper Benz & Wise Investment Counsel Inc

  • $1.21 Billion
  • Q3 2024

A detailed history of Schaper Benz & Wise Investment Counsel Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Schaper Benz & Wise Investment Counsel Inc holds 168,150 shares of ABT stock, worth $19.3 Million. This represents 1.58% of its overall portfolio holdings.

Number of Shares
168,150
Previous 166,097 1.24%
Holding current value
$19.3 Million
Previous $17.3 Million 11.07%
% of portfolio
1.58%
Previous 1.54%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$100.07 - $118.13 $205,443 - $242,520
2,053 Added 1.24%
168,150 $19.2 Million
Q2 2024

Aug 07, 2024
SELL
$100.73 - $112.44 $38,982 - $43,514
-387 Reduced 0.23%
166,097 $17.3 Million
Q1 2024

Apr 29, 2024
SELL
$109.52 - $120.96 $31,213 - $34,473
-285 Reduced 0.17%
166,484 $18.9 Million
Q4 2023

Feb 07, 2024
SELL
$90.19 - $110.4 $44,914 - $54,979
-498 Reduced 0.3%
166,769 $18.4 Million
Q3 2023

Oct 11, 2023
BUY
$95.53 - $114.62 $121,609 - $145,911
1,273 Added 0.77%
167,267 $16.2 Million
Q2 2023

Jul 17, 2023
SELL
$100.78 - $112.29 $12,799 - $14,260
-127 Reduced 0.08%
165,994 $18.1 Million
Q1 2023

May 01, 2023
SELL
$96.86 - $114.01 $71,773 - $84,481
-741 Reduced 0.44%
166,121 $16.8 Million
Q4 2022

Jan 25, 2023
SELL
$95.06 - $111.52 $360,277 - $422,660
-3,790 Reduced 2.22%
166,862 $0
Q3 2022

Oct 17, 2022
SELL
$96.76 - $112.03 $17,126 - $19,829
-177 Reduced 0.1%
170,652 $16.5 Million
Q2 2022

Aug 04, 2022
BUY
$102.07 - $123.37 $52,974 - $64,029
519 Added 0.3%
170,829 $18.6 Million
Q1 2022

Apr 29, 2022
SELL
$114.02 - $139.04 $253,352 - $308,946
-2,222 Reduced 1.29%
170,310 $20.2 Million
Q4 2021

Feb 10, 2022
SELL
$115.53 - $141.46 $129,740 - $158,859
-1,123 Reduced 0.65%
172,532 $24.3 Million
Q3 2021

Oct 27, 2021
SELL
$116.66 - $129.06 $114,560 - $126,736
-982 Reduced 0.56%
173,655 $20.5 Million
Q2 2021

Jul 29, 2021
BUY
$105.79 - $124.53 $23,802 - $28,019
225 Added 0.13%
174,637 $20.2 Million
Q1 2021

Apr 20, 2021
SELL
$108.84 - $128.23 $223,992 - $263,897
-2,058 Reduced 1.17%
174,412 $20.9 Million
Q4 2020

Feb 11, 2021
SELL
$105.0 - $114.42 $264,495 - $288,223
-2,519 Reduced 1.41%
176,470 $19.3 Million
Q3 2020

Nov 05, 2020
SELL
$91.64 - $111.29 $246,511 - $299,370
-2,690 Reduced 1.48%
178,989 $19.5 Million
Q2 2020

Jul 30, 2020
SELL
$76.57 - $98.0 $364,856 - $466,970
-4,765 Reduced 2.56%
181,679 $16.6 Million
Q1 2020

May 04, 2020
SELL
$62.82 - $91.86 $156,484 - $228,823
-2,491 Reduced 1.32%
186,444 $14.7 Million
Q4 2019

Jan 30, 2020
SELL
$78.51 - $87.4 $306,581 - $341,297
-3,905 Reduced 2.02%
188,935 $16.4 Million
Q3 2019

Nov 04, 2019
SELL
$81.84 - $88.74 $61,380 - $66,555
-750 Reduced 0.39%
192,840 $16.1 Million
Q2 2019

Aug 05, 2019
SELL
$72.88 - $85.0 $68,507 - $79,900
-940 Reduced 0.48%
193,590 $16.3 Million
Q1 2019

Apr 23, 2019
SELL
$66.22 - $80.06 $31,255 - $37,788
-472 Reduced 0.24%
194,530 $15.6 Million
Q4 2018

Feb 13, 2019
SELL
$65.56 - $74.27 $120,958 - $137,028
-1,845 Reduced 0.94%
195,002 $14.1 Million
Q3 2018

Oct 19, 2018
SELL
$60.81 - $73.36 $36,486 - $44,016
-600 Reduced 0.3%
196,847 $14.4 Million
Q2 2018

Aug 06, 2018
SELL
$57.57 - $63.54 $49,452 - $54,580
-859 Reduced 0.43%
197,447 $12 Million
Q1 2018

Apr 30, 2018
SELL
$56.27 - $63.62 $168,753 - $190,796
-2,999 Reduced 1.49%
198,306 $11.9 Million
Q4 2017

Jan 26, 2018
SELL
$53.68 - $57.47 $103,602 - $110,917
-1,930 Reduced 0.95%
201,305 $11.5 Million
Q3 2017

Nov 02, 2017
BUY
$48.06 - $53.64 $23,212 - $25,908
483 Added 0.24%
203,235 $10.8 Million
Q2 2017

Aug 07, 2017
BUY
N/A
202,752
202,752 $9.86 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Schaper Benz & Wise Investment Counsel Inc Portfolio

Follow Schaper Benz & Wise Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schaper Benz & Wise Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schaper Benz & Wise Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email